WHO Reports Malaria Eradication “Off Track,” Calls For More R&D, Scaling Up Commitments 28/08/2019 Rodolfo Tsapralis Amid stalled global progress on reducing malaria cases and deaths since 2015, the World Health Organization has called for renewed and accelerated research and development (R&D) of new tools for malaria prevention and treatment, improved use of data, and strengthened international, regional, and sub-national cooperation. WHO’s Strategic Advisory Group on Malaria Eradication (SAGme) said in […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows 22/07/2019 Editorial team [DNDi Press Release] Geneva/New Delhi – 22 July 2019 The results of an innovative “infectivity” study conducted by the Drugs for Neglected Diseases initiative (DNDi) and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known […] Continue reading -> Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection 27/06/2019 Editorial team [WHO News Release] Maputo/Geneva – The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported. New data presented today at the 22nd meeting of the WHO Alliance […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows 22/07/2019 Editorial team [DNDi Press Release] Geneva/New Delhi – 22 July 2019 The results of an innovative “infectivity” study conducted by the Drugs for Neglected Diseases initiative (DNDi) and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known […] Continue reading -> Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection 27/06/2019 Editorial team [WHO News Release] Maputo/Geneva – The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported. New data presented today at the 22nd meeting of the WHO Alliance […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows 22/07/2019 Editorial team [DNDi Press Release] Geneva/New Delhi – 22 July 2019 The results of an innovative “infectivity” study conducted by the Drugs for Neglected Diseases initiative (DNDi) and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known […] Continue reading -> Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection 27/06/2019 Editorial team [WHO News Release] Maputo/Geneva – The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported. New data presented today at the 22nd meeting of the WHO Alliance […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows 22/07/2019 Editorial team [DNDi Press Release] Geneva/New Delhi – 22 July 2019 The results of an innovative “infectivity” study conducted by the Drugs for Neglected Diseases initiative (DNDi) and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known […] Continue reading -> Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection 27/06/2019 Editorial team [WHO News Release] Maputo/Geneva – The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported. New data presented today at the 22nd meeting of the WHO Alliance […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows 22/07/2019 Editorial team [DNDi Press Release] Geneva/New Delhi – 22 July 2019 The results of an innovative “infectivity” study conducted by the Drugs for Neglected Diseases initiative (DNDi) and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known […] Continue reading -> Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection 27/06/2019 Editorial team [WHO News Release] Maputo/Geneva – The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported. New data presented today at the 22nd meeting of the WHO Alliance […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection 27/06/2019 Editorial team [WHO News Release] Maputo/Geneva – The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported. New data presented today at the 22nd meeting of the WHO Alliance […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Global Malaria Response: Extending The Reach Of Primary Health Care, Expanding Coverage Towards UHC 12/06/2019 David Branigan Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts